Publications

Saksena S, Sra J, Jordaens L, Kusumoto F, Knight B, Natale A, Kocheril A, Nanda NC, Nagarakanti R, Simon AM, Viggiano MA, Lockhandwala T, Chandler ML.  A prospective comparison of cardiac imaging using intracardiac echocardiography with transesophageal echocardiography in patients with atrial fibrillation: the intracardiac echocardiography guided cardioversion helps interventional procedures study.  Circ Arrhythm Electrophysiol 2010; 3:571-7.

Van Gelder IC, Wyse DG, Chandler ML, Cooper HA, Olshansky B, Hagens VE, Crijns HJGM and the RACE and AFFIRM Investigators.  Does intensity of rate-control influence outcome in atrial fibrillation?  An analysis of pooled data from the RACE and AFFIRM studies.  Europace 2006;8:935-942.

Kellen JC, Schron EB, Milne J, Chandler ML, Berg CM, Ritchie DA, Paterson D, Sweeney PA, Nelson JD, Mickel M, AFFIRM Investigators and Coordinators.  Perceived effects on patients’ health of participation in the atrial fibrillation follow-up ionvestigation of rhythm management study.  J Cardiovasc Nurs 2006;21(5):388-96.

Bush, D, Martin LW, Leman R, Chandler M, Haywood LJ and the NHLBI AFFIRM Investigators.  Atrial fibrillation among African Americans, Hispanics and Caucasians:  clinical features and outcomes from the AFFIRM Trial.  J Natl Med Assoc 2006;98:303-9.

O’Hara GE, Charbonneau L, Chandler M, Vidaillet HJ, Fillippon F, Sami M, Rocco TA, Padder FA, Champagne J, Pratt CM, Coutu B, Wyse DG, and the AFFIRM Investigators.  Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States.  Am J Cardiol 2005;96:815-21.

Montoro MN, Kjos SL, Chandler M, Peters RK, Xiang AH, Buchanan TA.  Insulin resistance and preeclampsia in gestational diabetes mellitus.  Diabetes Care 2005;28:1995-2000.

Olshansky B, Heller EN, Mitchell LB, Chandler M, Slater W, Green M, Brodsky M, Barrell P, Greene HL.  Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke?  Results from the AFFIRM study.  J Am Coll Cardiol 2005;45:2026-33.

Kaufman ES, Zimmermann PA, Wang T, Dennish GW, Barrell PD, Chandler ML, Greene HL and the AFFIRM Investigators.  Risk of proarrhythmic events in the AFFIRM study:  a multivariate analysis.  J Am Coll Cardiol 2004;44:1276-1282.

Cooper HA, Bloomfield DA, Bush DS, Katcher MS, Rawlins M, Sacco JD, Chandler M and the AFFIRM Investigators.  Relation between achieved heart rate and outcome in patients with atrial fibrillation.  Am J Cardiol 2004;93:1247-53.

Steinberg JS, Sadaniantz A, Kron J, Krahn A, Denny DM, Daubert J, Campbell WB, Havranek E, Murray K, Olshansky B, O’Neill G, Sami M, Schmidt S, Storm R, Zabalgoitia M, Miller J, Chandler M, Nasco EM, Greene HL.  Analysis of cause-specific mortality in the atrial fibrillation follow-up investigation of rhythm management study.  Circulation 2004;109:1973-80.

Oliveira J, Bailey C, Jones-Oliveira J, Dixon D, Gull D, Chandler M.  A computational model for the identification of biochemical pathways in the Krebs cycle.  Journal of Computational Biology 2003;10(1): 57-82.

Bird L, Young R, Chandler M, Anderson N. The effects of aminophylline and nifedipine on contractility of isolated pregnant human myometrium.  American Journal of Obstetrics and Gynecology 1987;157:171-79.